+ Watch CHD
on My Watchlist
The Company develops, manufactures and markets a range of household, personal care and specialty products.
Solid performer in a multi-year uptrend. Good dividend growth play.
Strong brands in Arm & Hammer, Trojan, Oxiclean, Nair, Xtra.Good international growth, showing the company can compete with P&G abroad. Aggressive marketing expenditures pay off as the company has seen improvement in the market share of five of it's eight 'power brands' in the first three quarters of the year.Acquisition of Avid has good potential to improve earnings going forward in one of the fastest growing segments in the industry.Focus on margins will drive earnings.
Arm & Hammer, First Response, Trojan, Nair, Orajel, OxiClean....and that is only the begining
For over thirty years, this company has steadily and consistently grown. I'm not inclined to bet that trend will end soon.
Value product line and growing brand name recognition
It seams to be growing every year.
Solid, profitable, makes inexpensive (and consumable) household goods. As globalism increases, more and more households will need the kinds of items they produce.
The slow but steady win the race - CHD is the slow and steady.
bb maven liked it . armand hammer products and orajel.
Consistent earnings and book value growth and a real strong stable of brands. Reminds me of a company called proctor and gamble that turned out ok ;)
Products are leaders in categories that won't be going away any time soon.
The Perfect "Buffet" Stock. Strong earnings growth due to a large competitive advantage in a product area that will never go away. CHD has seen it's net Income grow at about 25% annually over the past decade. Their business consists almost entirely of brand leaders like "Trojan", "Arm & Hammer" & "First Response." This growth will slow some in the US, but they have only begin to go global. Further, CHD has shown a lot of success with "tack on" acquisitions in the past of medium-market consumer goods that are too small for P&G to mess with. Shareholder Friendly Management. Management has shown that it is Shareholder friendly by judiciously expanding only when they see a good acquisition to be made instead of trying to build an empire. Further, their stock options are tied to metrics specific to each executive's actual job. Healthy Margin of Safety. Finally, this stock appears to be undervalued almost any way you value future cash flows. Depending on what you expect the future 10 year growth rate to be (12.5% to 15% is my expectation,) this stock can easily be valued at $85 to $100.
The Pope stated today that he believes that condoms could be helpful in the fight against the HIV virus. This is a huge development for condom manufacturers like Trojan, which is owned by Church & Dwight. This news has opened up a new market of customers who truly are in desperate need for this simple technology in Africa primarily, but also in Central and South America as well. The fact that this is a financially sound company only helps its standing with me.
Sort of a sneak attack. CHD is behind so many things people buy without ever wondering who makes it just because they need it.
a long term winner. looks pricey, but the price keeps rising, look at the history to see what I mean. They have been a consistent, growing, well run firm for 165 years! Who else can say that?
Technical Data indictates UP
PE lower than industry. People will always need their products and they pay dividends. Not a stock I'd expect to triple in a few years but good to have in a portfolio.
I am totally okay with this name. GO TROJANS!!!
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions